Just – Evotec Biologics

A new production plant in Toulouse in 2024

A new production plant for Evotec in Toulouse

JUST – Evotec Biologics develops biotherapeutic products ; from the design of therapeutic molecules to the design of facilities for their manufacture. A major international programme has been initiated with the start-up of a J.POD^® Redmond, WA (US). This first production unit will serve as a model for the J.POD^® Toulouse, France (EU), a new production plant located on the Curie campus in Toulouse.

This project has been financed by the government as part of the future investment programme and is also economically supported by the Occitanie region.

15 247 sqm

of total surface

3 950 sqm

of cleanrooms (excluding POD)

Classified area

Grade B, C, D, CNC, NC

Design and delivery of the project by Cap Ingelec

Within the framework of this project, Cap Ingelec is the general contractor for the GC2 macro-lot, which includes all the value-added infrastructures.

Our scope of work, in a high-stakes schedule, includes the delivery of 4,600 sqm of cGMP clean rooms, with controlled levels of dust, hygrometry and contamination, all distributed in High Current – CFO, Low Current – cfa (BMS/QBMS,…), hydraulics, aeraulics and special fluids. Our scope is completed by a Transverse Process Engineering Mission and is integrated into a collaborative work with the other lots (GC1 to GC6), with a performance qualification objective in June 2024.